McAlister A A - OmicsDI

Show results for

Unknown (292)
Proteomics (204)
Transcriptomics (1)
Genomics (1)

Organisms

Saccharomyces cerevisiae (197)
Rattus norvegicus (197)
Homo sapiens (197)
Shigella flexneri (197)
Shigella (197)
Arabidopsis thaliana (197)
Mus musculus (197)
Schizosaccharomyces pombe (196)
Oryza sativa Indica Group (196)
Sinorhizobium meliloti BL225C (196)
Sus scrofa domesticus (196)
Ostreococcus tauri (196)
Staphylococcus aureus (196)
Escherichia coli (196)
Candida albicans (196)
Cyanophora paradoxa (196)
Entamoeba histolytica (196)
Physcomitrium patens (196)
Methylohalobius crimeensis 10Ki (196)
Lotus japonicus (196)
Ctenopharyngodon idella (196)
Danio rerio (196)
Allexis (196)
Pseudomonas putida KT2440 (196)
Helicobacter pylori 26695 (196)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (196)
Zea mays (196)
Meleagris gallopavo (196)
Medicago truncatula (196)
Saccharomyces cerevisiae (1)

Organisms

Medicago truncatula (1)

Repository

pride (197)
MassIVE (4)
PAXDB (3)
biostudies-arrayexpress (1)
ENA (1)

Tissue

Cell culture (75)
Epithelial cell (15)
Cell suspension culture (9)
Fibroblast (8)
Brain (6)
Blood cell (5)
Macrophage (5)
Neutrophil (4)
Bone marrow (4)
Blood (4)
Colon (4)
Lung (4)
Heart (4)
Embryo (4)
Primary cell (3)
Leukocyte (3)
Liver (3)
HeLa cell (2)
Permanent cell line cell (2)
Monocyte (2)
Root (2)
B cell (2)
Skin (2)
Plant cell (2)
T cell (2)
Blood plasma (2)
Leaf (2)
Response to fungus (1)
HFF-1 cell (1)
Pseudostem (1)

Disease

Cryptococcosis (4)
Colon cancer (3)
Keratitis (2)
Human cytomegalovirus infection (2)
Cervix carcinoma (2)
Brain cancer (2)
Disease free (2)
Acute leukemia (2)
Cytomegalovirus retinitis (1)
Hypochromic anemia (1)
Hydrocephalus (1)
Epstein-Barr virus hepatitis (1)
Asthma (1)
Cryptococcal meningitis (1)
Anemia (1)
Non-small cell lung carcinoma (1)
Frontotemporal dementia (1)
Medulloblastoma (1)
Brain glioblastoma multiforme (1)
Lung carcinoma (1)
Melanoma (1)
Malaria (1)
Malignant neoplasm of ovary (1)
Lymphoma (1)
COVID-19 (1)
Renal fibrosis (1)
Prostate adenocarcinoma (1)
Pancreas adenocarcinoma (1)
Pancreatic ductal adenocarcinoma (1)
Cardiovascular system disease (1)

Technology Type

Mass Spectrometry (197)
Shotgun proteomics (147)
Bottom-up proteomics (41)
Data-dependent acquisition (26)
Affinity purification coupled with mass spectrometry proteomics (6)
Top-down proteomics (2)
Data-independent acquisition (2)
SWATH MS (1)

Instrument Platform

Orbitrap Ascend (4)
Orbitrap Eclipse (3)
Orbitrap Astral (1)

Publication Date

2023 (35)
2021 (27)
2022 (26)
2024 (24)
2025 (24)
2020 (18)
2026 (18)
2019 (12)
2018 (9)
2017 (7)
2015 (3)
2012 (1)
2016 (1)

UNIPROT ID/AC

A6TGR7_KLEP7 (3)
A6T6W6_KLEP7 (3)
A6THD2_KLEP7 (3)
A6TBY1_KLEP7 (3)
A6TAL8_KLEP7 (3)
A6T9U4_KLEP7 (3)
A6TFL6_KLEP7 (3)
Y006_KLEP7 (3)
A6T5G1_KLEP7 (3)
A6T6C0_KLEP7 (3)
A6TG79_KLEP7 (3)
A6T5Q4_KLEP7 (3)
A6T7I1_KLEP7 (3)
A6T4K4_KLEP7 (3)
MUG_KLEP7 (3)
RIHC_KLEP7 (3)
PEPQ_KLEP7 (3)
A6TG78_KLEP7 (3)
A6T7I2_KLEP7 (3)
A6T6W7_KLEP7 (3)
A6TAL7_KLEP7 (3)
A6THD3_KLEP7 (3)
LEUC_KLEP7 (3)
LSRF_KLEP7 (3)
A6T9K2_KLEP7 (3)
A6TFL5_KLEP7 (3)
A6TFB3_KLEP7 (3)
SYFA_KLEP7 (3)
A6TBR9_KLEP7 (3)
A6TC39_KLEP7 (3)

First Public Date

2018 (1)

Modification

N6 (1)
6x(2)H labeled dimethylated L-arginine (1)

Study type

Transcription profiling by array (1)

Release Date

2025 (40)
2023 (40)
2022 (28)
2020 (28)
2024 (21)
2021 (19)
2019 (15)
2017 (14)
2016 (13)
2018 (11)
2012 (10)
2015 (9)
2011 (7)
2014 (6)
2026 (4)
2010 (4)
2007 (4)
2009 (3)
2008 (3)
2006 (3)
2002 (3)
2013 (2)
2005 (2)
2004 (2)
2003 (1)
2001 (1)

Lab affiliation

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (36)
Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge, CB2 0XY, UK (7)
Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada (4)
Harvard Medical School (4)
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA (3)
Molecular and Cellular Biology Department, University of Guelph, 50 Stone Rd. E. Guelph, Ontario, Canada, N1G 2W1 (3)
Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada, N1G 2W1 (3)
University of Guelph (3)
Molecular and Cellular Biology, University of Guelph, Canada (3)
Department of Cell Biology, Harvard Medical School (3)
Cambridge Institute for Medical Research, University of Cambridge (3)
Department of Clinical Science, Faculty of Medicine, University of Bergen, Norway (3)
Goethe-Universität Frankfurt, Georg-Speyer-Haus, Paul-Ehrlich-Str. 42-44, Frankfurt am Main, GERMANY (2)
Department of Molecular and Cellular Biology, University of Guelph, 50 Stone Rd. E., Guelph, Ontario, Canada, N1G 2W1 (2)
Department of Molecular and Cellular Biology, University of Guelph, Canada. (2)
Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, Germany Structural Genomics Consortium (SGC), Buchmann Institute for Life Sciences, Max-von-Laue-Str. 15, 60438 Frankfurt am Main, Germany German Cancer Consortium (DKTK) Mainz/Frankfurt, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany (2)
Cambridge Institute for Medical Research, Hills Road, Cambridge, CB2 0XY (2)
Finley and Gygi lab Cell Biology Department Harvard Medical School US (2)
Michael Smith Laboratories, University of British Columbia (2)
Department of Cell Biology, Harvard Medical School, Boston, MA, USA (2)
Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany Frankfurt Cancer Institute, Frankfurt am Main, Germany Cardio-Pulmonary Institute, Frankfurt am Main, Germany (2)
University of Guelph 50 Stone Rd E Guelph, ON, Canada (1)
Life Sciences Institute, University of Michigan; Ann Arbor 48109, USA. (1)
Instituto de ecologia, A.C. (1)
Cell Biology (1)
Deparment of Molecular and Cellular Biology University of Guelph Guelph, Ontario, Canada Department of Proteomics and Signal Transduction Max Planck Institute of Biochemistry Martinsried, Germany (1)
Laboratory of Mass Spectrometry, BIOCEV, Faculty of Science Charles University in Prague (1)
Dana Farber Cancer Institute, Cancer Biology / Harvard Medical School, Biological Chemistry and Molecular Pharmacology (1)
Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran (1)
Cell Biology Harvard Medical School (1)

Previous page
1 / 50
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 50
Next page

Sort by:

Relevance

Page size

The impact of shifting demographics, variants of concern and vaccination on outcomes during the first 3 COVID-19 waves in Alberta and Ontario: a retrospective cohort study.

Not available

S-EPMC9121845 | biostudies-literature

Finding the right balance between precision medicine and personalized care.

Not available

S-EPMC5566606 | biostudies-literature

The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysis.

Not available

S-EPMC5047807 | biostudies-literature

Geographic clustering of emergency department presentations for acute coronary syndromes and heart failure in Alberta: a population-based study.

Not available

S-EPMC5498179 | biostudies-literature

The ecology of medical care for adults in Alberta, 2002/03 to 2016/17: a retrospective cohort study.

Not available

S-EPMC7082108 | biostudies-literature

Identifying subgroups of adult high-cost health care users: a retrospective analysis.

Not available

S-EPMC9022936 | biostudies-literature

Pay-for-performance remuneration for pharmacist prescribers' management of hypertension: A substudy of the RxACTION trial.

Not available

S-EPMC5089333 | biostudies-literature

Temporal and thermal optimization of trypsin digestion for the cryptococcal proteome

Mass spectrometry-based proteomics supports investigation into diverse biological systems, providing insights into regulation, signaling, modifications, and interactions. Optimized sample preparation is critical to ensure robust and reproducible analyses balanced with time and cost. In this article,...

ORGANISM(S): Cryptococcus neoformans var. grubii serotype A (strain H99 / ATCC 208821 / CBS 10515 / FGSC 9487) (Filobasidiella neoformans var. grubii)

2024-10-12 | PXD056755 | Pride

Secondary prevention treatment after acute stroke in older South Asian, Chinese and other Canadians: a retrospective data analysis.

Not available

S-EPMC5621941 | biostudies-literature

Cryptococcal infectome uncovers new therapeutic targets

Mortality and morbidity rates of invasive fungal infections are rising as new pathogens emerge, antifungal resistance rates rise, and susceptible populations increase in numbers. Innovative strategies to identify and characterize novel druggable targets and investigate mechanisms of action driving f...

ORGANISM(S): Cryptococcus neoformans var. grubii serotype A (strain H99 / ATCC 208821 / CBS 10515 / FGSC 9487) (Filobasidiella neoformans var. grubii)

2026-05-20 | PXD051675 | Pride

Virulence Fungal Infectome

Previous page
1 / 50
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 50
Next page

Sort by:

Relevance

Page size

498 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

First Public Date

Modification

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets